Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SZSE:300511'
s EV-to-FCF Range Over the Past 10 Years
Min: -145.16 Med: -4.22 Max: 590.21
Current: 14.96
During the past 13 years, the highest EV-to-FCF of Shanghai Xuerong Bio-Technology Co was 590.21. The lowest was -145.16. And the median was -4.22.
SZSE:300511's EV-to-FCF is ranked better than 53.38% of 1182
companies
in the Consumer Packaged Goods industry
Industry Median: 16.28
vs SZSE:300511: 14.96
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Xuerong Bio-Technology Co (SZSE:300511) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Xuerong Bio-Technology Co's PE Ratio (TTM) for today is calculated as:
Shanghai Xuerong Bio-Technology Co's share price for today is ¥5.83.
Shanghai Xuerong Bio-Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.270.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shanghai Xuerong Bio-Technology Co EV-to-FCF Related Terms
Shanghai Xuerong Bio-Technology Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Xuerong Bio-Technology Co EV-to-FCF Chart
For the Farm Products subindustry, Shanghai Xuerong Bio-Technology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Xuerong Bio-Technology Co EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Shanghai Xuerong Bio-Technology Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Shanghai Xuerong Bio-Technology Co's EV-to-FCF falls into.
Shanghai Xuerong Bio-Technology Co's current Enterprise Value is ¥4,613 Mil.
Shanghai Xuerong Bio-Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥306 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Xuerong Bio-Technology Co (SZSE:300511) has a EV-to-FCF of 15.09 as of Sep. 08, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Xuerong Bio-Technology Co and its competitors. According to the industry distribution chart, Shanghai Xuerong Bio-Technology Co ranks #551 out of 1182 companies in the Consumer Packaged Goods industry, placing it in the top 46.6%.
Is Shanghai Xuerong Bio-Technology Co's EV-to-FCF too high?
Shanghai Xuerong Bio-Technology Co's current EV-to-FCF is 15.09. The Consumer Packaged Goods industry median EV-to-FCF is 16.28. Shanghai Xuerong Bio-Technology Co's value of 15.09 is 7.3% below this industry median. Based on the distribution chart, Shanghai Xuerong Bio-Technology Co ranks #551 out of 1182 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Shanghai Xuerong Bio-Technology Co has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Xuerong Bio-Technology Co's EV-to-FCF compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Shanghai Xuerong Bio-Technology Co ranks #551 out of 1182 companies for EV-to-FCF. This puts Shanghai Xuerong Bio-Technology Co in the upper half of its industry. The industry median EV-to-FCF is 16.28. Shanghai Xuerong Bio-Technology Co's value of 15.09 is 7.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 16.28, based on 1,182 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Xuerong Bio-Technology Co's current EV-to-FCF of 15.09 is 7.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Xuerong Bio-Technology Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 16.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Xuerong Bio-Technology Co's current EV-to-FCF is 15.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Xuerong Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Xuerong Bio-Technology Co (SZSE:300511) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.43, compared to a current price of ¥5.83 — trading 31.6% above its estimated fair value. The current EV-to-FCF is 15.09 and 7.3% below the Consumer Packaged Goods industry median of 16.28. Shanghai Xuerong Bio-Technology Co's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shanghai Xuerong Bio-Technology Co (SZSE:300511), the current EV-to-FCF is 15.09 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Xuerong Bio-Technology Co (SZSE:300511) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Xuerong Bio-Technology Co stock appears to be overvalued.
The current stock price of ¥5.83 is trading 31.6% above its estimated GF Value™ of ¥4.43.
GuruFocus considers Shanghai Xuerong Bio-Technology Co to be Significantly Overvalued.
Key valuation signals for SZSE:300511:
EV-to-FCF: 15.09
GF Value™: ¥4.43 vs. price of ¥5.83 (31.6% above fair value)
Industry Position: 7.3% below the Consumer Packaged Goods median (#551 of 1182)
No single metric tells the full story. See the SZSE:300511 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Xuerong Bio-Technology Co Ltd is a bio-agricultural company, engages in the research, production, and marketing of edible fungi primarily in the People's Republic of China. It offers various mushroom products, such as white enoki, white-shimeji, brown-shimeji, seafood mushroom, king crab mushroom, king oyster mushroom, pleurotus nebrodensis, agaricus bisporus, and shiitake.
59GF Score
Get the complete analysis for SZSE:300511
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:300511 has been successfully added to your 
